Mefenorex
From Wikipedia, the free encyclopedia
![]() | |
Clinical data | |
---|---|
ATC code |
|
Legal status | |
Legal status |
|
Identifiers | |
CAS Number | |
PubChem CID | |
ChemSpider |
|
UNII | |
KEGG |
|
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.037.511 ![]() |
Chemical and physical data | |
Formula | C12H18ClN |
Molar mass | 211.731 g·mol−1 |
3D model (JSmol) | |
show
InChI
| |
Mefenorex (Rondimen, Pondinil, Anexate) is a stimulant drug which was used as an appetite suppressant. It is an amphetamine derivative which was developed in the 1970s and used for the treatment of obesity.[1][2] Mefenorex produces amphetamine as a metabolite,[3] and has been withdrawn in many countries despite having only mild stimulant effects and relatively little abuse potential.[4]
References[]
- ^ Vincendeau MJ (1970). "[A new regulator of appetite: mefenorex]". Bordeaux Medical (in French). 3 (7): 1951–3. PMID 5455004.
- ^ Beyer G, Huth K, Müller GM, Niemöller H, Raisp I, Vorberg G (February 1980). "[The treatment of obesity with the appetite curbing agent Mefenorex]". Die Medizinische Welt (in German). 31 (8): 306–9. PMID 7374423.
- ^ Rendić S, Slavica M, Medić-Sarić M (1994). "Urinary excretion and metabolism of orally administered mefenorex". European Journal of Drug Metabolism and Pharmacokinetics. 19 (2): 107–17. doi:10.1007/BF03188831. PMID 8001591. S2CID 7170057.
- ^ Engel J, Kristen G, Schaefer A, von Schlichtegroll A (June 1986). "Mefenorex (Rondimen)". Drug and Alcohol Dependence. 17 (2–3): 229–34. doi:10.1016/0376-8716(86)90010-4. PMID 3743406.
show
Stimulants | |
---|---|
Adamantanes |
|
Adenosine antagonists |
|
Alkylamines |
|
Ampakines | |
Arylcyclohexylamines |
|
Benzazepines |
|
Cathinones |
|
Cholinergics |
|
Convulsants |
|
Eugeroics |
|
Oxazolines |
|
Phenethylamines |
|
Phenylmorpholines |
|
Piperazines | |
Piperidines |
|
Pyrrolidines | |
Racetams |
|
Tropanes |
|
Tryptamines | |
Others |
|
ATC code: N06B |
show
Antiobesity agents/Anorectics (A08) | |||||||
---|---|---|---|---|---|---|---|
Central |
| ||||||
Peripheral |
| ||||||
|
show
Monoamine releasing agents | |||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
DRAs |
| ||||||||||||||
NRAs |
| ||||||||||||||
SRAs |
| ||||||||||||||
Others |
| ||||||||||||||
See also: Receptor/signaling modulators • Monoamine reuptake inhibitors • Adrenergics • Dopaminergics • Serotonergics • Monoamine metabolism modulators • Monoamine neurotoxins |
show
Phenethylamines | |
---|---|
Phenethylamines |
|
Amphetamines |
|
Phentermines |
|
Cathinones |
|
Phenylisobutylamines | |
Phenylalkylpyrrolidines | |
Catecholamines (and close relatives) |
|
Miscellaneous |
|
![]() | This drug article relating to the nervous system is a stub. You can help Wikipedia by . |
- v
- t
Retrieved from ""
Categories:
- Substituted amphetamines
- Organochlorides
- Norepinephrine-dopamine releasing agents
- Prodrugs
- Nervous system drug stubs
Hidden categories:
- CS1 French-language sources (fr)
- CS1 German-language sources (de)
- ECHA InfoCard ID from Wikidata
- Chem-molar-mass both hardcoded and calculated
- Articles without EBI source
- Chemical pages without DrugBank identifier
- All stub articles